Raw Material CAS 2156-56-1 Sodium Dichloroacetate Powder Pharmaceutical Sodium Dichloroacetate Powder Sodium Dichloroacetate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Sodium dichloroacetate
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Shelf Life: 2 Years
• Density: Relative Density (Water = 1): 1.56
• Melting Point: 198ºC (DEC.)
• Boiling Point: 194°cat760mmhg
• Flash Point: 194°cat760mmhg
• Psa: 40.13000
• Logp: -0.46000
• Safety Instructions: S26;S37/39
• Rtecs: AG9275000
• Dangerous Goods Shipping Code: R36/37/38
• CAS: 2156-56-1
• Similar Products: Sodium Dichloroacetate
• Sample: Available
• Usage: Pharmaceutical Intermediates
• Specific: COA
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

Raw Material CAS 2156-56-1 Sodium dichloroacetate powder Pharmaceutical Sodium dichloroacetate powder Sodium dichloroacetate

Product Description

Product Details

Other name	DCA
CAS	2156-56-1
Purity	99%
Appearance	White crystal powder
Usage	Pharmaceutical intermediates
Product Keywords	Sodiu

Sodium dichloroacetate is a metabolic regulator in cancer cells' mitochondria with anticancer activity. Sodium dichloroacetate inhibits PDHK, resulting in decreased lactic acid in the tumor microenvironment. Sodium dichloroacetate increases reactive oxygen species (ROS) generation and promotes cancer cell apoptosis. Sodium dichloroacetate also works as NKCC inhibitor.

Application&Function

 

Function

The only confirmed medical use for sodium dichloroacetate is for removing warts and other skin growths, according to the American Cancer Society. Researchers have tested it on humans for decreasing lactic acid buildup, or lactic acidosis, in rare diseases involving metabolism or caused by severe head injuries and malaria.

1. Anti-virus
2. Kill the cancer cells
3. Efficient anti-cancer raw materials
4. Control recurrence and metastasis

Specification